Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals
Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0b013e3182364c67
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)